Iron supplements for hair loss are widely discussed, yet their benefit depends entirely on whether iron deficiency is the underlying cause. Iron is essential for healthy hair follicle function, and depleted stores can trigger diffuse shedding known as telogen effluvium. However, hair loss is multifactorial, and supplementing without confirmed deficiency carries real risks. This article explains who may benefit from iron supplementation, which types are available in the UK, how to take them safely, what side effects to expect, and when to seek advice from your GP or a specialist.

Can Low Iron Cause Hair Loss?

Low iron can cause telogen effluvium — diffuse hair shedding — by depriving follicles of oxygen, though hair loss is multifactorial and diagnosis requires blood tests including serum ferritin, FBC, CRP, and thyroid function.

Not sure if this is normal? Chat with one of our pharmacists →

Iron is an essential mineral involved in numerous physiological processes, including the production of haemoglobin — the protein in red blood cells that carries oxygen to tissues throughout the body. Hair follicles are among the most metabolically active structures in the body, and they require a consistent supply of oxygen and nutrients to sustain healthy growth. When iron stores become depleted, follicle function can be compromised, potentially contributing to increased hair shedding.

The most commonly associated pattern is telogen effluvium, a condition in which a larger-than-normal proportion of hair follicles prematurely enter the resting (telogen) phase of the hair growth cycle, leading to diffuse shedding across the scalp. This type of hair loss is typically temporary and reversible once the underlying deficiency is corrected. Some research has also explored a possible association between low iron and female pattern hair loss (androgenetic alopecia), though the evidence here is inconclusive and no causal relationship has been established.

It is important to note that hair loss is multifactorial. Low iron is one of several potential contributing causes, alongside thyroid dysfunction, nutritional deficiencies (such as vitamin D, zinc, or B12), hormonal changes, stress, and autoimmune conditions. A diagnosis of iron-deficiency-related hair loss should therefore be based on clinical assessment and appropriate blood tests — including a full blood count (FBC), serum ferritin, C-reactive protein (CRP), and thyroid function tests — rather than assumed.

Serum ferritin is considered the most sensitive single marker of iron stores, but it is important to interpret results carefully. Ferritin is an acute-phase reactant, meaning levels can appear falsely normal or elevated in the presence of inflammation, infection, or liver disease, potentially masking true iron deficiency. Where inflammation is suspected, CRP and transferrin saturation should also be assessed. A ferritin level below 30 µg/L is generally consistent with iron deficiency; some clinicians consider higher thresholds (up to 50–70 µg/L) in the context of hair loss, but evidence supporting a specific target in this setting is limited and no universally agreed cut-off exists in current UK guidelines. Results should always be interpreted alongside the clinical picture and laboratory-specific reference ranges.

Who May Benefit from Iron Supplements for Hair Loss

Only individuals with confirmed iron deficiency benefit from supplementation; those at highest risk include women with heavy periods, vegetarians, and people with gastrointestinal malabsorption conditions.

Not everyone experiencing hair loss will benefit from iron supplementation. The potential benefit is most relevant to individuals who have a confirmed iron deficiency, identified through blood tests and clinical assessment. Certain groups are at higher risk of low iron stores and may therefore be more likely to see an improvement in hair health following supplementation.

Groups who may be at increased risk of iron deficiency include:

• Women with heavy menstrual periods (menorrhagia)

• Pregnant or postpartum women

• Individuals following vegetarian or vegan diets, as plant-based (non-haem) iron is less readily absorbed

• People with gastrointestinal conditions such as coeliac disease or Crohn's disease, or those who have undergone bariatric surgery

• Frequent blood donors

• Adolescents during periods of rapid growth

For individuals in these groups who are also experiencing diffuse hair shedding, it is reasonable to investigate iron status as part of a broader assessment. If iron deficiency is confirmed, correcting it — through dietary changes and/or supplementation — may help to reduce shedding and support hair regrowth over time.

It is equally important to recognise that supplementing with iron when levels are already normal or high carries no proven benefit for hair loss and may in fact be harmful. Iron overload can cause serious organ damage, and individuals with conditions such as haemochromatosis or other iron overload disorders should not take iron supplements unless specifically advised to do so by a specialist.

A further important consideration relates to the underlying cause of iron deficiency. In adult men and postmenopausal women, iron deficiency anaemia (IDA) is less commonly explained by dietary factors alone and may indicate occult gastrointestinal blood loss. In these groups, UK guidance from the British Society of Gastroenterology (BSG) recommends gastrointestinal evaluation, and an urgent suspected cancer referral under NICE NG12 may be appropriate depending on associated symptoms. Any new diagnosis of IDA in these groups should therefore prompt prompt GP review rather than self-directed supplementation.

Types of Iron Supplement Available in the UK

Ferrous sulphate is the first-line UK supplement for iron deficiency; modified-release preparations are not recommended, and hair, skin, and nail supplements contain insufficient iron to correct a clinical deficiency.

A range of iron supplements is available in the UK, both on prescription and over the counter. They differ in terms of the form of iron they contain, their elemental iron content, tolerability, and cost.

Ferrous salts are the most commonly prescribed forms in the UK and are considered first-line for treating iron deficiency. These include:

• Ferrous sulphate — the most widely used and cost-effective option, available on NHS prescription and over the counter; a standard 200 mg tablet provides approximately 65 mg of elemental iron

• Ferrous fumarate — often better tolerated than ferrous sulphate by some individuals; a 210 mg tablet provides approximately 68 mg of elemental iron

• Ferrous gluconate — contains a lower amount of elemental iron per tablet (approximately 35 mg per 300 mg tablet) and may cause fewer gastrointestinal side effects

It is important to note that modified-release or enteric-coated ferrous preparations are generally not recommended. Although sometimes marketed as better tolerated, these formulations release iron beyond the duodenum and proximal jejunum — the primary sites of absorption — resulting in significantly reduced bioavailability.

Ferric iron preparations, such as ferric maltol (Feraccru®), are licensed in the UK for the treatment of IDA in adults and may be an option when standard ferrous salts are not tolerated or have proved inadequate. They tend to be more expensive and are typically reserved for specific clinical situations, such as in people with inflammatory bowel conditions.

In recent years, liquid iron supplements and iron bisglycinate formulations have become popular as over-the-counter options, often marketed as being gentler on the stomach. Whilst some individuals report finding these more tolerable, comparative evidence for their superiority over standard ferrous salts in terms of efficacy is limited, and tolerability varies between individuals.

Food supplements marketed for hair, skin, and nails often contain low doses of iron alongside other nutrients. These are not equivalent to therapeutic iron supplementation and are unlikely to correct a clinically significant deficiency. If iron deficiency has been confirmed, a dedicated iron supplement at an appropriate therapeutic dose is more appropriate than a general multivitamin or beauty supplement.

Recommended Doses and How to Take Iron Safely

Current UK guidance supports starting with one ferrous sulphate 200 mg tablet daily; iron is best taken on an empty stomach, and alternate-day dosing may improve absorption and reduce side effects.

Experiencing these side effects? Our pharmacists can help you navigate them →

The appropriate dose of iron supplementation depends on whether the aim is to treat an established deficiency or to maintain adequate levels in someone at risk. Current UK guidance from NICE and the British Society for Haematology (BSH) supports starting with one ferrous sulphate 200 mg tablet daily (providing approximately 65 mg of elemental iron) rather than routinely prescribing two to three tablets daily, as was previously common practice. The dose may be adjusted based on response and tolerability. For iron deficiency without anaemia — which is more commonly associated with hair loss — lower doses are often sufficient.

Alternate-day dosing (taking iron every other day rather than daily) has been shown in some studies to improve net absorption and reduce gastrointestinal side effects, and may be considered where daily dosing is not well tolerated. This approach is increasingly recognised in UK clinical practice, though it is not yet universally adopted.

To maximise absorption, iron supplements are best taken on an empty stomach, approximately 30 minutes before a meal. If gastrointestinal side effects are problematic, taking iron with a small amount of food can help, though this may reduce absorption slightly.

Tips for taking iron effectively:

• Avoid taking iron alongside tea, coffee, dairy products, or calcium supplements, as these can inhibit absorption

• Leave an adequate gap between iron and other medications — at least four hours is recommended for levothyroxine, tetracyclines, and fluoroquinolone antibiotics; check the BNF or your medicine's patient information leaflet for specific guidance

• Other medicines that may interact include bisphosphonates, levodopa/carbidopa, and antacids or proton pump inhibitors (which reduce stomach acid and can impair iron absorption)

• Routine co-administration of vitamin C to enhance absorption is not necessary and is not recommended in current UK guidance

• Modified-release iron preparations should be avoided due to reduced bioavailability (see above)

Monitoring: If treating iron deficiency anaemia, a haemoglobin (Hb) response is typically expected within two to four weeks. Once Hb has normalised, supplementation is usually continued for approximately three months to replenish iron stores, as advised by a clinician. Ferritin and Hb should be rechecked to confirm adequate repletion before stopping treatment.

Possible Side Effects and Interactions to Be Aware Of

The most common side effects are gastrointestinal, including constipation, nausea, and dark stools; iron significantly reduces absorption of levothyroxine, tetracyclines, fluoroquinolones, and bisphosphonates if taken simultaneously.

Iron supplements are generally safe when taken at recommended doses, but they are associated with a number of well-recognised side effects, particularly affecting the gastrointestinal tract. These are among the most common reasons people discontinue treatment.

Common gastrointestinal side effects include:

• Nausea and stomach discomfort

• Constipation (most common)

• Diarrhoea

• Dark or black stools — this is a harmless and expected effect of iron supplementation, but should be distinguished from melaena (black, tarry, foul-smelling stools), which can indicate gastrointestinal bleeding and requires urgent medical attention

• Abdominal cramping or bloating

Seek urgent medical advice if you experience black tarry stools with an offensive smell, vomiting blood, severe abdominal pain, or dizziness and fainting, as these may be signs of gastrointestinal bleeding rather than a side effect of iron.

If side effects are troublesome, switching to a lower-dose preparation, taking iron with food, or trying an alternate-day dosing schedule may help. Ferrous gluconate and iron bisglycinate are often reported as better tolerated, though individual responses vary.

In terms of drug interactions, iron can significantly reduce the absorption of several medications. Clinically important interactions include:

• Levothyroxine — separate by at least four hours

• Tetracyclines and fluoroquinolone antibiotics — separate by at least four hours

• Bisphosphonates (used for osteoporosis)

• Levodopa and carbidopa (used in Parkinson's disease)

• Antacids and proton pump inhibitors — these reduce stomach acid and can impair iron absorption

Always check the BNF or your medicine's patient information leaflet for specific interaction advice, and inform your pharmacist or GP of all medicines you are taking.

It is important to keep iron supplements out of reach of children. Accidental ingestion of iron tablets by young children can cause severe, potentially life-threatening poisoning; if this occurs, seek urgent medical attention immediately. If you experience unexpected or concerning side effects from iron supplements, you can report these to the MHRA via the Yellow Card scheme (yellowcard.mhra.gov.uk).

When to Seek Advice from Your GP or a Specialist

Consult your GP if hair loss is significant, persistent beyond three months, or accompanied by fatigue, pallor, or other systemic symptoms; self-prescribing iron without investigation is not recommended.

Whilst mild hair shedding can be a normal response to temporary stressors, certain patterns of hair loss warrant prompt medical assessment. It is advisable to consult your GP if you notice significant or persistent hair loss, particularly if it is accompanied by other symptoms that might suggest an underlying medical condition.

Reasons to contact your GP include:

• Noticeable thinning or diffuse shedding lasting more than three months

• Hair loss accompanied by fatigue, breathlessness, pallor, or dizziness — which may suggest iron deficiency anaemia

• Patchy hair loss, which could indicate alopecia areata or another dermatological condition

• Scarring of the scalp, a painful or inflamed scalp, or sudden rapid hair loss — these may suggest a scarring alopecia requiring specialist assessment

• Hair loss alongside symptoms of thyroid dysfunction, such as unexplained weight changes, cold intolerance, or palpitations

• Features of hyperandrogenism in women, such as acne, hirsutism, or irregular menstrual periods

• A family history of significant hair loss combined with early-onset thinning

• No improvement in hair shedding after three to six months of confirmed iron repletion

Your GP can arrange relevant blood tests, including a full blood count, serum ferritin, CRP, thyroid function tests, and other markers as clinically indicated (such as B12, folate, and coeliac serology where appropriate). If an underlying cause is identified and treated, hair regrowth can often be expected, though this may take six to twelve months as the hair growth cycle is slow.

In adult men and postmenopausal women found to have iron deficiency anaemia, UK guidance from the BSG recommends investigation for a gastrointestinal source of blood loss. Depending on associated symptoms, an urgent suspected cancer referral under NICE NG12 may be appropriate. Your GP will advise on the most suitable pathway.

If the cause of hair loss remains unclear or hair loss is severe, your GP may refer you to a dermatologist or specialist trichology service. A referral to a haematologist may be appropriate if iron deficiency is recurrent or unexplained, to rule out malabsorption or occult blood loss.

Self-prescribing iron supplements without prior investigation is not recommended. Taking iron unnecessarily carries risks, and addressing the root cause of hair loss — rather than supplementing empirically — is always the safer and more effective approach.

Frequently Asked Questions